Loading page…
Company intelligence / Live profile
Track OpenEvidence's role in the AI economy through Superpower Daily reporting on policy, tools, and models. This live company page updates automatically as new launches, partnerships, product moves, and market signals are published.
Latest coverage
Key developments
The dismissal closes a dispute that grew from alleged efforts to extract AI secrets into a defamation countersuit. Each company will cover its own legal fees.
An analysis covering 950,000 U.S. clinicians shows how they use the medical AI platform. Whether that use improves patient care remains unanswered.
The rollout gives verified clinicians a choice between answers measured in seconds and literature investigations measured in minutes. Its strongest performance claims, however, come from company-run evaluations, while Darwin remains gated over stated dual-use concerns.
Your company watchlist